Ashish Banerjee Clinical Oncology Society of Australia Annual Scientific Meeting 2022

Abstracts this author is presenting:

• Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial — Poster session 1